280 related articles for article (PubMed ID: 15579981)
1. Continuing challenges in the management of retinoblastoma with chemotherapy.
Shields CL; Meadows AT; Leahey AM; Shields JA
Retina; 2004 Dec; 24(6):849-62. PubMed ID: 15579981
[TBL] [Abstract][Full Text] [Related]
2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in the management of retinoblastoma.
Shields CL; Shields JA
J Pediatr Ophthalmol Strabismus; 1999; 36(1):8-18; quiz 35-6. PubMed ID: 9972509
[TBL] [Abstract][Full Text] [Related]
4. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
5. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
6. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
7. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for retinoblastoma: a current topic.
Finger PT; Czechonska G; Demirci H; Rausen A
Drugs; 1999 Dec; 58(6):983-96. PubMed ID: 10651386
[TBL] [Abstract][Full Text] [Related]
9. Current treatment of retinoblastoma.
De Potter P
Curr Opin Ophthalmol; 2002 Oct; 13(5):331-6. PubMed ID: 12218465
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
[TBL] [Abstract][Full Text] [Related]
11. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
12. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
13. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
[TBL] [Abstract][Full Text] [Related]
14. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
[TBL] [Abstract][Full Text] [Related]
15. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors.
Shields CL; Shields JA; Cater J; Othmane I; Singh AD; Micaily B
Ophthalmology; 2001 Nov; 108(11):2116-21. PubMed ID: 11713089
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
[TBL] [Abstract][Full Text] [Related]
17. Chemoreduction in the initial management of intraocular retinoblastoma.
Shields CL; De Potter P; Himelstein BP; Shields JA; Meadows AT; Maris JM
Arch Ophthalmol; 1996 Nov; 114(11):1330-8. PubMed ID: 8906023
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
[TBL] [Abstract][Full Text] [Related]
19. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
20. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]